News
New Zealand invests $61.8m to boost diagnostic capacity
New Zealand invests $61.8m to boost diagnostic capacity
31 replacement and seven new scanners will be installed across 14 hospitals.
NHG Health, DFI Retail Group partner to expand preventive health access
The healthcare group will provide clinical expertise and research capabilities.
New regulatory regime for clinics and SPCs now in effect
The DH is now accepting clinic licence and exemption applications.
Eye health investment could yield $5.6b in economic benefit for Indonesia
Potential gains include $1.92b from improved occupational productivity.
Hong Kong moves forward with Chinese Medicine Development Blueprint
The blueprint will be published by the end of the year.
Western Australia invests additional $328.5m in health infrastructure
This brings the total investment to $2.43b (A$3.7b) over the next four years.
Design team appointed for new paediatric hospice at Westmead
Construction timeframes will be confirmed following the appointment of a builder.
ADB greenlights $370m grant to support health services in Afghanistan
The funding will benefit 17 provinces.
Patient handling equipment market to be valued at $26.76b by 2033
This is thanks to rising investments in hospital infrastructure and home care services.
Multi-cancer early detection testing market to reach $7.52b by 2033
By end-user, hospitals and clinics accounted for $950m in 2024.
SALAM Shah Alam Specialist Hospital inks MoU with City University Malaysia
The partnership focuses on student engagement and internship opportunities.
New integrated heatlh learning hub opens in Melbourne’s east
The facility is expected to host 3,000 students each year.
Redcliffe Hospital trials new tech for precise antibiotic dosing
It uses data and computer modelling combined with blood test results.
Permanent ultrasound services launched at Chatham Islands Health Centre
The system allows routine scans with remote guidance from Christchurch Hospital.
Saudi and Syrian ministers eye cooperation between health and culture
Both sides explored ways to integrate cultural initiatives with health programmes.
Rare disease therapeutics market to hit $495.27b by 2033
The sector’s growth is attributed to gene therapies and RNA-based treatments.
8MM atrial fibrillation market to fall to $10.5b by 2032
The decline is attributed to the drop in sales of novel oral anticoagulants.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation